tiprankstipranks
Armata Pharmaceuticals Inc (ARMP)
:ARMP
US Market

Armata Pharmaceuticals (ARMP) Income Statement

Compare
257 Followers

Armata Pharmaceuticals Income Statement

Last quarter (Q3 2024), Armata Pharmaceuticals's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Armata Pharmaceuticals's net income was $-5.48M. See Armata Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 4.53M$ 5.51M$ 4.47M$ 823.00K$ 0.00
Gross Profit
$ -29.24M$ 4.62M$ -15.54M$ -13.62M$ -1.35M
Operating Expenses
$ 11.65M$ 36.95M$ 23.82M$ 21.59M$ 19.09M
Depreciation and Amortization
$ 972.00K$ 892.00K$ 1.17M$ 1.11M$ 1.35M
EBITDA
$ -39.92M$ -36.05M$ -22.65M$ -20.44M$ -19.75M
Operating Income
$ -40.89M$ -36.95M$ -23.82M$ -21.59M$ -19.75M
Other Income/Expenses
$ -28.16M$ 29.00K$ 667.00K$ -594.00K$ 273.00K
Pretax Income
$ -69.05M$ -36.92M$ -23.16M$ -22.18M$ -19.48M
Net Income
$ -69.05M$ -36.89M$ -23.22M$ -22.82M$ -19.02M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.91$ -1.08$ -0.96$ -1.39$ -2.43
Diluted EPS
$ -1.91$ -1.08$ -0.96$ -1.39$ -2.43
Weighted Average Shares Outstanding
36.08M 34.29M 24.10M 16.42M 7.83M
Weighted Average Shares Outstanding (Diluted)
36.08M 34.29M 24.10M 16.42M 7.83M
Currency in USD

Armata Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis